Determining the Safety of L-serine in ALS

Clinical trial NCT01835782 · UNKNOWN

Trial details

NCT number: NCT01835782
Sponsor: Phoenix Neurological Associates, LTD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2013-01-01
Primary completion: 2016-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.